An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.

Diabetologist Dr Arora emphasises the importance of 6 tests every 6 months for maintaining health as they aid in early disease detection and overall well-being.

Elafibranor (Iqirvo) was well tolerated and led to sustained improvements in liver enzyme levels and itch severity through 28 weeks in patients with primary sclerosing cholangitis (PSC), according to ...

One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is ...

The single dose treatment helped patients lower “bad” cholesterol and triglyerides, both linked to heart disease ...

CRISPR Therapeutics' CEO said he hoped to have a product on the market in the next four or five years. Read more at ...

In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and ...

Creatine is a safe and effective supplement with very few side effects, unless taken at higher doses than recommended.

Monthly olezarsen reduced triglycerides by 65% for people with severe hypertriglyceridemia, resulting in a greater than 85% ...

A sluggish liver refers the organ’s impaired function, leading to poor detoxification and other functions. Some symptoms of the same can include fatigue, digestive issues like bloating or constipation ...

In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like ...

Doctors in Belgium met with a real head-scratcher when an 83-year-old married man came in with a rare form of secondary ...